Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Stoppa

Showing results (81-90 of 138) with videos related to

Pageof 14
Sort By:
Leukemia|January 1, 1992
Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literatureB Quesnel, H Kantarjian, J P Bjergaard, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|July 1, 1988
Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentationM F Bertheas, D Maraninchi, M Lafage, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignanciesM H Gaspard, D Maraninchi, A M Stoppa, et al.
Bone Marrow Transplantation|January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remissionD Blaise, M H Gaspard, A M Stoppa, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation|February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remissionH de Lavallade, C Faucher, S Fürst, et al.
Pageof 14

Showing results (81-90 of 138) with videos related to

Sort By:
Pageof 14
Leukemia|January 1, 1992
Is allogeneic bone marrow transplantation the best treatment for young adult patients with acute myeloid leukemia in first complete remission. The BGMT GroupJ Reiffers, A M Stoppa, F Rigal-Huguet, et al.
Stem Cells (Dayton, Ohio)|August 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma. A report of the French Registry on Autologous Transplantation in Multiple MyelomaJ L Harousseau, M Attal, M Divine, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 1993
Therapy-related acute myeloid leukemia with t(8;21), inv(16), and t(8;16): a report on 25 cases and review of the literatureB Quesnel, H Kantarjian, J P Bjergaard, et al.
Blood|June 1, 1995
Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French Registry on autologous transplantation in multiple myelomaJ L Harousseau, M Attal, M Divine, et al.
Blood|July 1, 1988
Partial chimerism after T-cell-depleted allogeneic bone marrow transplantation in leukemic HLA-matched patients: a cytogenetic documentationM F Bertheas, D Maraninchi, M Lafage, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1988
Intensive chemotherapy with high doses of BCNU, etoposide, cytosine arabinoside, and melphalan (BEAM) followed by autologous bone marrow transplantation: toxicity and antitumor activity in 26 patients with poor-risk malignanciesM H Gaspard, D Maraninchi, A M Stoppa, et al.
Bone Marrow Transplantation|January 1, 1990
Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remissionD Blaise, M H Gaspard, A M Stoppa, et al.
Bone Marrow Transplantation|August 3, 2004
Mycophenolate mofetil and cyclosporine for graft-versus-host disease prophylaxis following reduced intensity conditioning allogeneic stem cell transplantationM Mohty, H de Lavallade, C Faucher, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
Treatment of chronic myelogenous leukemia with interleukin-2: a phase II study in 21 patientsN Vey, D Blaise, M Lafage, et al.
Bone Marrow Transplantation|February 14, 2006
Allogeneic stem cell transplantation after reduced-intensity conditioning in a patient with T-cell prolymphocytic leukemia: graft-versus-tumor effect and long-term remissionH de Lavallade, C Faucher, S Fürst, et al.
Pageof 14